John Lillig has over 40 years’ experience in the management & guidance of clinical diagnostics & life science businesses. John joined Dynex Technologies in March 2017 as its Executive Chairman. He also serves as Executive Chairman of Agena Bioscience, a clinical diagnostics targeted DNA analysis products company and as a Director of Carterra, a high throughput antibody characterization products company.
Before Agena, John served as Senior VP and Managing Director of the Brooks Life Science Systems Division of Brooks Automation. Prior to Brooks, John was the Founder, Chairman, CEO of Nexus Biosystems which was acquired by Brooks Automation and, prior to Nexus, John served as CTO for Discovery Partners International (DPI) and VP/GM of DPI’s Drug Discovery Systems Division. Before DPI he served as Division Manager of the Analytical Systems Division of Bio-Rad Laboratories. Earlier in his career, John held several key management positions during his 19 years at Beckman Instruments’ Clinical Diagnostics & Life Science operations. John has 17 patents and received his B.S. in Engineering from California Polytechnic University.